Cargando…

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study

PURPOSE: We evaluated the dose-responsiveness, efficacy, and safety of low-dose triple antihypertensive combination therapies in patients with mild-to-moderate hypertension. PATIENTS AND METHODS: After a 1 to 2-week placebo run-in period, 248 patients were randomized to the half-dose triple combinat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Soon Jun, Sung, Ki-Chul, Lim, Sang-Wook, Kim, Seok-Yeon, Kim, Weon, Shin, Jinho, Park, Sungha, Kim, Hae-Young, Rhee, Moo-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781016/ https://www.ncbi.nlm.nih.gov/pubmed/33408462 http://dx.doi.org/10.2147/DDDT.S286586

Ejemplares similares

Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension
por: Sung, Ki‐Chul, et al.
Publicado: (2023)

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial
por: Sung, Ki‐Chul, et al.
Publicado: (2022)

A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy
por: Jeon, Eun-Seok, et al.
Publicado: (2022)

A Randomized, Multicenter, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Quadruple Combination of Amlodipine, Losartan, Rosuvastatin, and Ezetimibe in Patients with Concomitant Essential Hypertension and Dyslipidemia
por: Kim, Min Chul, et al.
Publicado: (2023)

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study [Corrigendum]
Publicado: (2021)

Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial
por: Cho, Eun Joo, et al.
Publicado: (2023)

2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension
por: Kim, Hyeon Chang, et al.
Publicado: (2019)

2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension
por: Lee, Hae-Young, et al.
Publicado: (2019)

2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations
por: Kim, Kwang-il, et al.
Publicado: (2019)

Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study
por: Cho, In-Jeong, et al.
Publicado: (2021)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
por: Kim, Sung H, et al.
Publicado: (2011)

Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial
por: Serrano, José C. E., et al.
Publicado: (2023)

Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
por: Oh, Gyu Chul, et al.
Publicado: (2017)

Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
por: Kang, Min-gu, et al.
Publicado: (2019)

Suboptimal Management Status of Younger Hypertensive Population in Korea
por: Lee, Hae-Young, et al.
Publicado: (2021)

A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy
por: Ahn, Youngkeun, et al.
Publicado: (2018)

Antihypertensive and Renal Protective Effects of Oryeongsan in Spontaneously Hypertensive Rats
por: Kang, Kiwan, et al.
Publicado: (2020)

The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
por: Kim, Hack-Lyoung, et al.
Publicado: (2023)

Transition of May Measurement Month to an online hypertension awareness campaign in Korea during the COVID-19 pandemic
por: Shin, Jinho, et al.
Publicado: (2021)

Statement on chronotherapy for the treatment of hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Antihypertensive Treatment in Severe Aortic Stenosis
por: Kang, Tae Soo, et al.
Publicado: (2018)

Prevalence and characteristics of isolated nocturnal hypertension in the general population
por: Rhee, Moo-Yong, et al.
Publicado: (2021)

Resistant hypertension: consensus document from the Korean society of hypertension
por: Park, Sungha, et al.
Publicado: (2023)

Higher Blood Pressure Variability in White Coat Hypertension; from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kang, In Sook, et al.
Publicado: (2016)

Smartphone / smartwatch-based cuffless blood pressure measurement : a position paper from the Korean Society of Hypertension
por: Lee, Hae Young, et al.
Publicado: (2021)

Characteristics of Individuals with Disagreement between Home and Ambulatory Blood Pressure Measurements for the Diagnosis of Hypertension
por: Kim, Chee Hae, et al.
Publicado: (2020)

Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure
por: Park, Sungha
Publicado: (2019)

Combined antihypertensive effect of unripe Rubus coreanus Miq. and Dendropanax morbiferus H. Lév. Extracts in 1 kidney-1 clip hypertensive rats and spontaneously hypertensive rats
por: Park, Soyi, et al.
Publicado: (2021)

Erratum to: Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data
por: Choi, Sung Il, et al.
Publicado: (2016)

Prevention of radiotherapy induced enteropathy by probiotics (PREP): protocol for a double-blind randomized placebo-controlled trial
por: Kim, Yeon Joo, et al.
Publicado: (2021)

Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study
por: Han, Seung Jin, et al.
Publicado: (2015)

Prevalence of resistant hypertension and associated factors for blood pressure control status with optimal medical therapy using Korean ambulatory blood pressure monitoring registry data
por: Choi, Sung Il, et al.
Publicado: (2016)

Medical visits, antihypertensive prescriptions and medication adherence among newly diagnosed hypertensive patients in Korea
por: Jeong, Hyoseon, et al.
Publicado: (2017)

Clinical features and predictors of masked uncontrolled hypertension from the Korean Ambulatory Blood Pressure Monitoring Registry
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Office blood pressure threshold of 130/80 mmHg better predicts uncontrolled out‐of‐office blood pressure in apparent treatment‐resistant hypertension
por: Lee, Chan Joo, et al.
Publicado: (2020)

Comparative, randomized, double-blind clinical study of alveolar ridge preservation using an extracellular matrix-based dental resorbable membrane in the extraction socket
por: Chang, Hyeyoon, et al.
Publicado: (2017)

Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study design
por: Nuotio, Marja-Liisa, et al.
Publicado: (2022)

The Effects of Antihypertensive Drugs on Bone Mineral Density in Ovariectomized Mice
por: Kang, Kwi Young, et al.
Publicado: (2013)

Algorithm for diagnosing hypertension using out‐of‐office blood pressure measurements
por: Kim, Je Sang, et al.
Publicado: (2021)

Home blood pressure monitoring: a position statement from the Korean Society of Hypertension Home Blood Pressure Forum
por: Ihm, Sang-Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nujnaoeunkt07bakp8i86gstif